Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910. | Cancer Sci | 2023 | 37189003 | PubTator, text mining | PubMed |
| Mutual Regulation of ncRNAs and Chromatin Remodeling Complexes in Normal and Pathological Conditions. | Int J Mol Sci | 2023 | 37175555 | PubTator, text mining | PubMed |
| Zinc Finger Proteins in the War on Gastric Cancer: Molecular Mechanism and Clinical Potential. | Cells | 2023 | 37174714 | PubTator, text mining | PubMed |
| Hereditary colorectal, gastric, and pancreatic cancer: comprehensive review. | BJS Open | 2023 | 37165697 | PubTator, text mining | PubMed |
| Structure of WNT inhibitor adenomatosis polyposis coli down-regulated 1 (APCDD1), a cell-surface lipid-binding protein. | Proc Natl Acad Sci U S A | 2023 | 37155902 | PubTator, text mining | PubMed |
| Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer. | ESMO Open | 2023 | 37148593 | PubTator, text mining | PubMed |
| Receptors that bind to PEDF and their therapeutic roles in retinal diseases. | Front Endocrinol (Lausanne) | 2023 | 37139333 | PubTator, text mining | PubMed |
| Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type. | Int J Mol Sci | 2023 | 37108755 | PubTator, text mining | PubMed |
| Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network. | Mol Oncol | 2023 | 37097008 | PubTator, text mining | PubMed |
| Visinin-like 1, a novel target gene of the Wnt/β-catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer. | Cancer Med | 2023 | 37096864 | PubTator, text mining | PubMed |
| Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer. | Cancer Med | 2023 | 37096801 | PubTator, text mining | PubMed |
| The Unique Spectrum of MUTYH Germline Mutations in Colombian Patients with Extracolonic Carcinomas. | Appl Clin Genet | 2023 | 37096204 | PubTator, text mining | PubMed |
| Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer. | J Inflamm Res | 2023 | 37092128 | PubTator, text mining | PubMed |
| The association between age at breast cancer diagnosis and prevalence of pathogenic variants. | Breast Cancer Res Treat | 2023 | 37084156 | PubTator, text mining | PubMed |
| Pancreatic cancer: Advances and challenges. | Cell | 2023 | 37059070 | PubTator, text mining | PubMed |
| Minimal Residual Disease in Colorectal Cancer: Are We Finding the Needle in a Haystack? | Cells | 2023 | 37048141 | PubTator, text mining | PubMed |
| The Role of WNT Pathway Mutations in Cancer Development and an Overview of Therapeutic Options. | Cells | 2023 | 37048063 | PubTator, text mining | PubMed |
| Wnt Signaling Inhibitors and Their Promising Role in Tumor Treatment. | Int J Mol Sci | 2023 | 37047705 | PubTator, text mining | PubMed |
| Molecular genetics of early-onset colorectal cancer. | World J Biol Chem | 2023 | 37034132 | PubTator, text mining | PubMed |
| Intraductal oncocytic papillary neoplasm (IOPN): two case reports and review of the literature. | Transl Cancer Res | 2023 | 37033351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=19